UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 29, 2023
McKESSON CORPORATION
(Exact Name of Registrant as Specified in Charter)
| Delaware | 1-13252 | 94-3207296 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
6555 State Hwy 161
Irving, TX 75039
(Address of Principal Executive Offices, and Zip Code)
(972) 446-4800
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading | Name of each exchange on which registered | ||
| Common stock, $0.01 par value | MCK | New York Stock Exchange | ||
| 1.500% Notes due 2025 | MCK25 | New York Stock Exchange | ||
| 1.625% Notes due 2026 | MCK26 | New York Stock Exchange | ||
| 3.125% Notes due 2029 | MCK29 | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 7.01 | Regulation FD Disclosure. |
McKesson Corporation (the “Company”) today announced that Britt Vitalone, Executive Vice President and Chief Financial Officer will assume expanded leadership, adding responsibility for McKesson’s Technology Organization and Mergers & Acquisitions, effective October 3, 2023. The new organizational structure will increase alignment across the teams and further advance McKesson’s strategy under new leadership.
Vitalone has been with McKesson for 17 years and has served as a financial executive leader in several major businesses within the Company and has been the Executive Vice President and Chief Financial Officer since 2018.
Francisco Fraga has been newly appointed as Executive Vice President, Chief Information Officer and Chief Technology Officer. Fraga will assume the role effective immediately and will report to Britt Vitalone in his new capacity. Prior to the new role, Fraga was Senior Vice President and Chief Information Officer for Pharmaceutical Solutions and Services and has been with McKesson since 2021.
The information contained in this item is furnished to the Securities and Exchange Commission (the “Commission”) but shall not be deemed “filed” with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, except as expressly stated in any such filing.
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 29, 2023, Nancy Avila, Executive Vice President, Chief Information Officer and Chief Technology Officer stepped down from her role and as an executive officer of the Company effective October 2, 2023. Avila has agreed to continue employment with the Company through January 1, 2024, to assist with transition activities.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 3, 2023
| McKesson Corporation | ||
| By: | /s/ Lori A. Schechter | |
| Lori A. Schechter | ||
| Executive Vice President, Chief Legal Officer | ||
| and General Counsel | ||